Carlsmed, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| – | +269.5% | +151.1% | |
| – | +319.5% | +156.7% | |
| – | +455.6% | +113.8% | |
| – | +455.6% | +173.6% | |
| – | +113.8% | +67.9% | |
| – | +73.0% | +85.4% | |
| – | +103.6% | -74.5% | |
| – | +18.5% | +61.9% | |
| – | -79.1% | +67.5% | |
| – | +42.4% | +85.8% | |
| – | +106.3% | -0.4% | |
| – | – | – | |
| – | – | – | |
| – | +272.6% | -14.1% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.